Clinical Trial Update: Observational Study of MIRCERA in Users of Self-Application and Multidose Systems

View source ↗

Summary

Observational study of MIRCERA (pegylated epoetin beta) in users of self-application and multidose systems completed; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Renal Anemia of Chronic Kidney Disease | Status: COMPLETED | Results posted: 2015-12-22